Investigating E-cigarette Particle Emissions and Human Airway Depositions under Various E-cigarette Use Conditions.
E-cigarette use is dramatically increasing, particularly with adolescents. While the chemical composition of e-liquids and e-vapor are well characterized, the particle size distribution and the human airways deposition patterns of e-cigarette particles are understudied and poorly understood despite their likely contribution to adverse health effects from e-cigarette usage. In this study, we studied the impacts of e-cigarette device power, e-liquid composition, and vaping topography on e-cigarette particle sizes and their deposition in human airways. In addition, we observed that particle measurement conditions (dilution ratio, temperature, and humidity) significantly affect measured e-cigarette particle sizes. E-cigarette power output significantly increased particle count median diameters (CMD) from 174±13 nm (particles generated under 6.4-watt) to 236±14 nm (particles generated under 31.1-watt). E-cigarette particles generated from propylene glycol-based e-liquids (CMD = 145±8 nm and mass median diameter [MMD] = 3.06±0.17 µm) were smaller than those generated from vegetable glycerin-based e-liquids (CMD = 182±9 nm and MMD = 3.37±0.21 µm). Puff volume also impacted vapor particle size: CMD and MMD were 154±11 nm and 3.50±0.27 µm, 163±6 nm and 3.35±0.24 µm, and 146±12 nm and 2.95±0.14 µm, respectively, for 35, 90, and 170 ml puffs. Estimated e-cigarette particle mass deposition fractions in tracheobronchial and bronchoalveolar regions were 0.504-0.541 and 0.073-0.306, respectively. Interestingly, e-cigarette particles are smaller than the particles generated from cigarette smoking but have similar human airway deposition patterns.